A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD
Conditions
Facioscapulohumeral Muscular Dystrophy · FSHD · FSHD - Facioscapulohumeral Muscular Dystrophy · FSHD1 · FSHD2 · Fascioscapulohumeral Muscular Dystrophy · Fascioscapulohumeral Muscular Dystrophy Type 1 · Fascioscapulohumeral Muscular Dystrophy Type 2 · Facioscapulohumeral Muscular Dystrophy 1 · Facioscapulohumeral Dystrophy · Facio-Scapulo-Humeral Dystrophy · Facioscapulohumeral Muscular Dystrophy 2 · Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1) · FSH Muscular Dystrophy · Landouzy Dejerine Dystrophy · Landouzy-Dejerine Muscular Dystrophy · Landouzy-Dejerine Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of California Irvine, Orange, California, United States
Stanford University, Palo Alto, California, United States
University of Colorado, Denver, Colorado, United States
University of Florida, Gainesville, Florida, United States
University of Iowa, Iowa City, Iowa, United States
Kansas University Medical Center, Kansas City, Kansas, United States
Kennedy Krieger Institute, Baltimore, Maryland, United States
University of Massachusetts, Worcester, Massachusetts, United States
University of Rochester Medical Center, Rochester, New York, United States
Duke University, Durham, North Carolina, United States
Ohio State University, Columbus, Ohio, United States
University of Pennsylvania, Philadelphia, Pennsylvania, United States
University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
Virginia Commonwealth University, Richmond, Virginia, United States
University of Calgary - Cumming School of Medicine, Calgary, Alberta, Canada
University of Alberta Hospital, Edmonton, Alberta, Canada
The Ottawa Hospital, Ottawa, Ontario, Canada
Genge Partners Inc, Montreal, Quebec, Canada
Aarhus University Hospital, Aarhus, Denmark
Rigshospitalet, Copenhagen, Denmark
Centre de Reference des Maladies Neuromusculaires et de la SLA - AP-HM Hopital de La Timone, Marseille, France
CHU de Montpellier - Hopital Gui de Chauliac, Montpellier, France
CHU de Nice - Hopital Pasteur 2 - Centre de reference des Maladies Neuromusculaires, Nice, France
AP-HP Hopital Pitie-Salpetriere, Paris, France
Universitaetsklinikum Bonn, Bonn, Germany
Georg-August-Universitaet Goettingen Stiftung oeffentlichen Rechts Universitaetsmedizin Goettingen, Göttingen, Germany
Klinikum der Ludwig-Maximilians-Universitaet Muenchen, München, Germany
Universitaetsklinikum Ulm, Ulm, Germany
Fondazione Serena ETS - Centro Clinico NeMO Milano, Milan, Italy
Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
Azienda Ospedaliero-Universitaria Sant'Andrea, Roma, Italy
Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Roma, Italy
National Hospital Organization Osaka Toneyama Medical Center, Osaka, Japan
The University of Osaka Hospital, Osaka, Japan
National Hospital Organization Sendai Nishitaga Hospital, Sendai, Japan
National Center of Neurology and Psychiatry, Tokyo, Japan
Academisch Ziekenhuis Leiden, Leiden, Netherlands
Stichting Radboud Universitair Medisch Centrum, Nijmegen, Netherlands
Hospital Universitari de Bellvitge, Barcelona, Spain
Hospital Universitario Vall d'Hebron, Barcelona, Spain
Hospital Universitario Donostia, San Sebastián, Spain
Hospital Universitari i Politecnic La Fe, Valencia, Spain
National Hospital for Neurology & Neurosurgery, London, United Kingdom
St. George's University Hospitals NHS Foundation Trust, London, United Kingdom
Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom
Royal Hallamshire Hospital, Sheffield, United Kingdom